Search results
Cancer vaccines are having a renaissance
Technology Review· 3 days agoPersonalized cancer vaccines like the ones Moderna and BioNTech are developing are tailored to each patient’s particular cancer. Together these neoantigens form a kind of ...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 4 days agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 4 days agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK (NYSE:GSK)
Benzinga· 4 days agoVaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 3 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 5 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on...
BioPharma-Reporter· 5 days agoAlmost half of all strategic alliances focused on RNA therapies over the last five years in the...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 4 days ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 2 days agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has been fighting a class-action ...